Will Stevens
BSc, MSc, PhD
Senior Programmer/Analyst
Will is a senior programmer/analyst at the Clinical Trials Services Unit & Epidemiological Studies Unit (CTSU).
He works on software for transforming clinical trial data into a form compliant with standards published by the Clinical Data Interchange Standards Consortium (CDISC). CDISC standards facilitate data sharing and submission of clinical trial data to regulatory agencies. Will has been involved with several CDISC-related groups and committees including the CDISC European Coordinating Committee (E3C) and the CDISC UK Network.
Will has a bachelor’s degree in Computer Science, a master’s degree in Mathematics, and a PhD from the Department of Physics and Astronomy at the Open University. His interests and expertise include: CDISC standards, algorithm development and optimization, software design, testing strategy, efficient use of software and data technologies, multi-paradigm programming. Favourite programming languages: C/C++, Python, SQL, LISP, R.
He joined CTSU in 2013, having previously worked in software design and development for several projects in industry and in academic clinical trials.
Recent publications
-
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Journal article
EMPA-KIDNEY Collaborative Group None. et al, (2024), N Engl J Med
-
ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.
Journal article
Sammons EL. et al, (2024), Ophthalmology, 131, 771 - 779
-
Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England.
Journal article
Pessoa-Amorim G. et al, (2024), Trials, 25
-
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Journal article
EMPA-KIDNEY Collaborative Group None., (2024), The lancet. Diabetes & endocrinology, 12, 51 - 60